https://www.takeda.com/en-ca/newsroom/2026/fruzaqla-ontario-metastatic-colorectal-cancer-treatment/
Fruzaqla Reimbursed in Ontario for Colorectal Cancer Treatment
Fruzaqla capsules now funded in Ontario for metastatic colorectal cancer, offering new hope for patients. Learn more about its benefits and availability.
colorectal cancerfruzaqlaontariotreatment
https://www.businesswire.com/news/home/20240620305780/en/Takeda-Receives-Approval-from-European-Commission-for-FRUZAQLA-in-Previously-Treated-Metastatic-Colorectal-Cancer
Takeda Receives Approval from European Commission for FRUZAQLA in Previously Treated Metastatic...
Takeda (TSE:4502/NYSE:TAK) today announced that the European Commission (EC) approved FRUZAQLA (fruquintinib) as a monotherapy indicated for the treatment of...
european commission
https://www.medicines.org.uk/emc/product/15999/pil
FRUZAQLA 1 mg hard capsules - Patient Information Leaflet (PIL) - (emc) | 15999
FRUZAQLA 1 mg hard capsules - Patient Information Leaflet (PIL) by Takeda UK Ltd
patient information leaflet1 mghard capsulesfruzaqla
https://www.medicines.org.uk/emc/product/16000/pil
FRUZAQLA 5 mg hard capsules - Patient Information Leaflet (PIL) - (emc) | 16000
FRUZAQLA 5 mg hard capsules - Patient Information Leaflet (PIL) by Takeda UK Ltd
patient information leaflethard capsulesfruzaqlamg
https://www.mckesson.com/about-us/newsroom/press-releases/2023/fruzaqla-fda-approved-treatment-metastatic-colorectal-cancer/
FRUZAQLA (fruquintinib), FDA Approved for the Treatment of Metastatic Colorectal Cancer, Available...
Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare diseases, was selected by Takeda as a specialty pharmacy provider...
metastatic colorectal cancerfda approvedfor the
https://www.fda.gov/drugs/drug-trials-snapshots/drug-trials-snapshots-fruzaqla
Drug Trials Snapshots: FRUZAQLA | FDA
Drug Trials Snapshots: FRUZAQLA
drug trialssnapshotsfruzaqlafda